Topical Sirolimus 0.2% Gel for the Management of Tuberous Sclerosis Complex-Related Cutaneous Manifestations: An Interim Analysis of Postmarketing Surveillance in Japan
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource, 1 online resource.
- Language
-
Englisch
- Bibliographic citation
-
Topical Sirolimus 0.2% Gel for the Management of Tuberous Sclerosis Complex-Related Cutaneous Manifestations: An Interim Analysis of Postmarketing Surveillance in Japan ; volume:13 ; number:5 ; day:11 ; month:3 ; year:2023 ; pages:1113-1126 ; date:5.2023
Dermatology and therapy ; 13, Heft 5 (11.3.2023), 1113-1126, 5.2023
- Creator
-
Egami, Akemi
Takahashi, Shinji
Kokubo, Takeshi
Boggarapu, Sreedevi
Beresford, Eric
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s13555-023-00914-2
- URN
-
urn:nbn:de:101:1-2023090510534664916005
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:48 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Egami, Akemi
- Takahashi, Shinji
- Kokubo, Takeshi
- Boggarapu, Sreedevi
- Beresford, Eric
- SpringerLink (Online service)
Other Objects (12)
Improved health-related quality of life in patients treated with topical sirolimus for facial angiofibroma associated with tuberous sclerosis complex
Sirolimus in Infants with Multiple Cardiac Rhabdomyomas Associated with Tuberous Sclerosis Complex
Neurological manifestations of tuberous sclerosis complex: the importance of early diagnosis
Topical rapamycin inhibits tuberous sclerosis tumor growth in a nude mouse model
Rare manifestations and malignancies in tuberous sclerosis complex: findings from the TuberOus SClerosis registry to increAse disease awareness (TOSCA)
Everolimus versus sirolimus for angiomyolipoma associated with tuberous sclerosis complex: a multi-institutional retrospective study in China
Histological spectrum of pulmonary manifestations in kidney transplant recipients on sirolimus inclusive immunosuppressive regimens
Cutaneous Manifestations of Sarcoidosis Seen in a Patient with a History of Tuberous Sclerosis
Superimposed mosaicism in tuberous sclerosis complex: a key to understanding all of the manifold manifestations?
Safety and efficacy of Rapamune® (Sirolimus) in kidney transplant recipients: results of a prospective post-marketing surveillance study in Korea
Optimization, Formulation, and Stability of Topical Rapamycin Used for Rare Tuberous Sclerosis Disease: from Ointment to Liposomes
Renal manifestations of tuberous sclerosis complex: patients’ and parents’ knowledge and routines for renal follow-up – a questionnaire study
Improved health-related quality of life in patients treated with topical sirolimus for facial angiofibroma associated with tuberous sclerosis complex
Sirolimus in Infants with Multiple Cardiac Rhabdomyomas Associated with Tuberous Sclerosis Complex
Neurological manifestations of tuberous sclerosis complex: the importance of early diagnosis
Topical rapamycin inhibits tuberous sclerosis tumor growth in a nude mouse model
Rare manifestations and malignancies in tuberous sclerosis complex: findings from the TuberOus SClerosis registry to increAse disease awareness (TOSCA)
Everolimus versus sirolimus for angiomyolipoma associated with tuberous sclerosis complex: a multi-institutional retrospective study in China
Histological spectrum of pulmonary manifestations in kidney transplant recipients on sirolimus inclusive immunosuppressive regimens
Cutaneous Manifestations of Sarcoidosis Seen in a Patient with a History of Tuberous Sclerosis
Superimposed mosaicism in tuberous sclerosis complex: a key to understanding all of the manifold manifestations?
Safety and efficacy of Rapamune® (Sirolimus) in kidney transplant recipients: results of a prospective post-marketing surveillance study in Korea
Optimization, Formulation, and Stability of Topical Rapamycin Used for Rare Tuberous Sclerosis Disease: from Ointment to Liposomes
Renal manifestations of tuberous sclerosis complex: patients’ and parents’ knowledge and routines for renal follow-up – a questionnaire study
Improved health-related quality of life in patients treated with topical sirolimus for facial angiofibroma associated with tuberous sclerosis complex
Sirolimus in Infants with Multiple Cardiac Rhabdomyomas Associated with Tuberous Sclerosis Complex
Neurological manifestations of tuberous sclerosis complex: the importance of early diagnosis
Topical rapamycin inhibits tuberous sclerosis tumor growth in a nude mouse model
Rare manifestations and malignancies in tuberous sclerosis complex: findings from the TuberOus SClerosis registry to increAse disease awareness (TOSCA)
Everolimus versus sirolimus for angiomyolipoma associated with tuberous sclerosis complex: a multi-institutional retrospective study in China
Histological spectrum of pulmonary manifestations in kidney transplant recipients on sirolimus inclusive immunosuppressive regimens
Cutaneous Manifestations of Sarcoidosis Seen in a Patient with a History of Tuberous Sclerosis
Superimposed mosaicism in tuberous sclerosis complex: a key to understanding all of the manifold manifestations?
Safety and efficacy of Rapamune® (Sirolimus) in kidney transplant recipients: results of a prospective post-marketing surveillance study in Korea
Optimization, Formulation, and Stability of Topical Rapamycin Used for Rare Tuberous Sclerosis Disease: from Ointment to Liposomes